PA Good Doctor (1833 HK) – 2022 preview: Solid business development through the bumpy 2022
Going forward, we expect PAGD’s business to regain positive growth of +23%/ +20% YoY in 2023E/ 24E, considering the post-pandemic business resumption
249 Views
PA Good Doctor (1833 HK) - Early Achievements of Strategy 2.0
1H22 earnings in line. PA Good Doctor (PAGD) reported 1H22 revenue of RMB2,828mn, down by 26% YoY and adjusted non-IFRS net loss of RMB390mn.
200 Views
Longfor, AAC Technology, Ping An
Markets are treacherous, but none more than Hong Kong listed stocks. The vicious short-covering rallies and an impulse selloff have become a...
262 Views
New Warrants & DLCs tracking BYD, Meituan, AliHealth & Ping An Health
Investors can now gain exposure to a wider range of Hong Kong stocks via SGX-listed Warrants and DLCs with recent new listings. Warrants and...
299 Views